tiprankstipranks
Gossamer Bio Inc (GOSS)
NASDAQ:GOSS

Gossamer Bio (GOSS) Financial Statements

659 Followers

Gossamer Bio Financial Overview

Gossamer Bio's market cap is currently ―. The company's EPS TTM is $-1.052; its P/E ratio is -1.00; Gossamer Bio is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $0.51. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -38.80M$ -44.91M$ -36.66M$ -39.07M$ -45.66M
EBITDA$ -37.81M$ -43.90M$ -38.07M$ -39.15M$ -45.67M
Net Income Common Stockholders$ -41.93M$ -48.15M$ -40.01M$ -42.50M$ -49.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 244.39M$ 296.43M$ 328.89M$ 162.13M$ 201.86M
Total Assets$ 259.36M$ 311.92M$ 347.93M$ 181.75M$ 219.91M
Total Debt$ 9.59M$ 12.57M$ 16.24M$ 19.88M$ 23.48M
Net Debt$ -234.81M$ -283.85M$ -312.65M$ -142.25M$ -178.38M
Total Liabilities$ 232.64M$ 249.15M$ 243.31M$ 244.55M$ 248.36M
Stockholders Equity$ 26.69M$ 62.77M$ 104.62M$ -62.82M$ -28.46M
Cash Flow-
Free Cash Flow$ -52.30M$ -33.42M$ -34.49M$ -38.31M$ -52.95M
Operating Cash Flow$ -52.30M$ -33.42M$ -34.49M$ -38.31M$ -52.95M
Investing Cash Flow$ 61.67M$ -14.37M$ -118.26M$ 12.94M$ 8.72M
Financing Cash Flow$ -2.56M$ -2.90M$ 198.50M$ -2.90M$ -2.54M
Currency in USD

Gossamer Bio Earnings and Revenue History

Gossamer Bio Debt to Assets

Gossamer Bio Cash Flow

Gossamer Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis